Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

allergan

Allergan acquires Chase Pharma in potential $1 billion deal

November 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Allergan announced that it has completed the acquisition of Chase Pharmaceutical Corporation in a deal worth a potential $1 billion. …
News
anthony_maddaluna

Anthony Maddaluna, executive vice president of Pfizer, to retire

November 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Anthony J. Maddaluna, who worked at Pfizer for more than 41 years, will retire from his positions of executive vice …
Appointment
sun_pharma

Sun Pharma makes strategic Russian firm acquisition

November 23, 2016 Research and Development, Sales and Marketing Biosintez, Russia, Sun Pharma

Sun Pharmaceutical, India’s largest pharmaceutical company, has acquired Russian pharmaceutical company JSC Biosintez in a total deal of $60 million. …
News

Pfizer set to develop new $200 million site

November 23, 2016 Manufacturing and Production, Research and Development Pfizer, manufacturing and production

Pfizer plans to expand its operations in St. Louis, Missouri, by developing a $200 million facility in Chesterfield. The site …
News

Scientists identify an existing drug that could aid in therapy for brain swelling

November 23, 2016 Medical Communications, Research and Development University of Arkansas, concussion, head injury

A team of biomedical engineering researches, who performed their study at the University of Arkansas, have identified a drug that …
News
shutterstock_141299494

University of Toronto develops circulating tumour cell monitoring tool

November 22, 2016 Research and Development University of Toronto, circulating cancer cells

Researchers at the University of Toronto have developed a new tool which promises to enable the monitoring and profiling of …
News
thomas_willemsen

Thomas Willemson promoted to China Area Head at GSK

November 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GlaxoSmithKline appointed a new area head in Thomas Willemsen to take charge of its China drug business. He succeeds Herve …
Appointment
jj_2johnson_and_johnson

J&J and Genmab’s drug races to second line treatment approval

November 22, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Genmab, Janssen, Johnson & Johnson, darzalex, multiple myeloma

Janssen, a part of Johnson & Johnson, and Genmab have announced that their multiple myeloma drug Darzalex (daratumumab) has been …
News
astrazeneca_building_white

AstraZeneca allowed to recruit for drug trial again

November 22, 2016 Manufacturing and Production, Research and Development AstraZeneca, FDA, clinical trial

AstraZeneca’s clinical trial for head and neck cancer had previously been put on partial hold by the FDA due to …
News

Acorda forced to stop development of drug

November 21, 2016 Manufacturing and Production, Research and Development Acorda therapeutics, clinical trial, post-stroke

Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …
News
dna-163466

China conducts first gene-editing human trial

November 21, 2016 Research and Development, Sales and Marketing China, DNA, cas9, crispr

China has used Crispr/Cas9 gene-editing technology to edit the DNA of a human subject, suffering from metastatic lung cancer. This …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Crohn's, Janssen, otezla, top ten

While the world is still reeling from the US presidential election results; it’s business as usual for the pharma industry; …
News
clinical_trial

GSK/J&J release how their drug measures up against Humira

November 18, 2016 Medical Communications, Research and Development GSK, Humira, Janssen, Johnson & Johnson, sirukumab

GlaxoSmithKline and Janssen, part of Johnson & Johnson, released the results of their two Phase III trials exploring treatment options …
News
flag_of_japan_

Japan to slash Opdivo costs by 50%

November 17, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, opdivo

Japan’s health ministry has announced it is to slash the price of Bristol-Myers Squibb’s Opdivo by 50% in the country …
News
amgen_hq

Amgen boosted in race to market for migraine drug

November 17, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Novartis, erenumab, migraine, phase III

Amgen released positive results from their second Phase III trial for experimental migraine drug, known as erenumab, which it is …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025